Abivax SA American Depositary Shares

Here is the public summary page for Abivax SA American Depositary Shares. Please login to see the complete information for Abivax SA American Depositary Shares including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Abivax SA American Depositary Shares stacks up relative to its peers.


Darwin Score+31
TickerABVX
Latest Price66.49 USD as of close on 25-Jul-2025
3 Month price range5.67 to 69.76 USD
Market Capitalisation4.43Bn USD
CountryUnited States of America
RegionNorth America
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryBiotechnology
Sub-IndustryBiotechnology
Description
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
See More ...
Company URLhttps://www.abivax.com
See Darwins Full Analysis for Abivax SA American Depositary Shares

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Abivax SA American Depositary Shares. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages+30
SentimentNews and Candle Patterns. 0
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.0
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.+1

Peer Comparison

There are 27 peers of Abivax SA American Depositary Shares.
Asset NameIndustry GroupPerf(20d)%Asset Score
ACADIA Pharmaceuticals Inc (ACAD)Biotechnology+4.7+9
Amgen Inc (AMGN)Biotechnology+9.8+22
Arrowhead Pharmaceuticals Inc (ARWR)Biotechnology-2.1-24
BioMarin Pharmaceutical Inc (BMRN)Biotechnology+9.1-19
Biogen Inc (BIIB)Biotechnology+3.6-13
Black Diamond Therapeutics Inc (BDTX)Biotechnology+20.7+1
Cyclacel Pharmaceuticals Inc (CYCC)Biotechnology+205.7-26
Dynavax Technologies Corp (DVAX)Biotechnology+14.3+2
Exelixis Inc (EXEL)Biotechnology+5.8+30
FibroGen Inc (FGEN)Biotechnology+40.6-14
Gilead Sciences Inc (GILD)Biotechnology+8.0+19
Halozyme Therapeutics Inc (HALO)Biotechnology+10.9+8
Humacyte Inc (HUMA)Biotechnology+14.0+1
Incannex Healthcare Ltd ADR (IXHL)Biotechnology+402.4-19
Incyte Corp (INCY)Biotechnology-0.9-2
Krystal Biotech Inc (KRYS)Biotechnology+3.5-5
MacroGenics Inc (MGNX)Biotechnology+34.6+1
Moderna Inc (MRNA)Biotechnology+24.0+14
Myriad Genetics Inc (MYGN)Biotechnology-16.5-14
Neurocrine Biosciences Inc (NBIX)Biotechnology+4.3+21
NuCana PLC (NCNA)Biotechnology-27.8-16
OPKO Health Inc (OPK)Biotechnology+3.8-6
Regeneron Pharmaceuticals Inc (REGN)Biotechnology+8.1+2
Replimune Group Inc (REPL)Biotechnology-66.7-19
United Therapeutics Corp (UTHR)Biotechnology+7.2-2
Vertex Pharmaceuticals Inc (VRTX)Biotechnology+5.9+20
Vir Biotechnology Inc (VIR)Biotechnology+6.4-16

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn